Genetic variation in CYP2E1, which has been documented in the Chinese population (Huang et al., 2012), is an established cause of significant inter-individual differences in drug response and the risk of neurodegenerative disease (Sheng et al., 2021). Here, CYP2E1 is linked to neurodegenerative disease.